Navigation Links
FDA Approves Picato® (ingenol mebutate) Gel, the First and Only Topical Actinic Keratosis (AK) Therapy With 2 or 3 Consecutive Days of Once-Daily Dosing
Date:1/25/2012

erythema, flaking/scaling, crusting and swelling. 

"LEO Pharma is committed to helping people achieve healthy skin. We are pleased to introduce Picato® gel, a new treatment option for patients with actinic keratosis, a common precancerous condition," said John Koconis, President and CEO, LEO Pharma Inc. "The approval of Picato® gel in the United States is another step forward in helping us realize our vision of becoming a preferred dermatology care partner worldwide."   

For more information about Picato® gel, including full prescribing information, please visit www.leo-pharma.us/home/products/LEO-pharma-products.aspx.

About Actinic Keratosis
Actinic keratosis (AK) is a dry, scaly, rough-textured patch or lesion that forms on the outermost layer of the skin after cumulative exposure to ultraviolet (UV) light, such as sunlight. In some cases, the lesions may be easier to feel than see. The name actinic keratosis literally means "sun-induced rough spot" and therefore the lesions, which can be gray, pink, red or the same color as the skin, are often called sun spots and/or age spots.

A job that requires spending hours of time outside, or everyday activities such as gardening, exercise or attending outdoor sporting events, can lead to sun damage if skin isn't adequately protected. People at high risk are often fair-skinned men and women over the age of 40 who may have accumulated a significant amount of sun exposure over the course of many years.[1]

About Picato® (ingenol mebutate) gel, 0.015%, 0.05%
Picato® gel is indicated for the topical treatment of actinic keratosis.

To date, 18 clinical trials have been completed for the use of Picato® gel, from phase I trials through pivotal phase III trials. In phase III clinical trials, 60-68 percent of patients with actinic k
'/>"/>

SOURCE LEO Pharma Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 24, 2014  Novastem, a leader in regenerative ... in its study for ischemic stroke at Clinica ... ischemic strokes account for 87 percent of all ... in the study, entitled "Internal Research Protocol in ... Stem Cells and Intrathecal Administration of Neural Stem ...
(Date:12/24/2014)... China, Dec. 24, 2014 /PRNewswire/  -- Tianyin Pharmaceutical ... pharmaceutical company that specializes in the patented biopharmaceutical, ... active pharmaceutical ingredients (API) released unaudited preliminary financial ... 2015. Fiscal Year 2015 Ended September ... $9.7 million compared with $14.7 million in 1Q14 ...
(Date:12/24/2014)...  The International Trade Commission (ITC) issued its final decision ... In a notice issued on December 23, the ITC ruled ... its humidifier was invalid. BMC President, James ... very excited with the ITC,s decision in this case. This ... since the very beginning on the key patents in the ...
Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12ITC Final Decision Goes Against ResMed (RMD) Monumental Win for 3B/BMC 2
... Janssen Alzheimer Immunotherapy, together with its collaborator ... pleased to announce the Alzheimer,s Association™, the world,s ... and research, as a new beneficiary of ... Everything campaign. Through this campaign, mountaineer and ...
... DIEGO, May 10, 2011 /PRNewswire/ -- Pf enex ... Pf enex Expression Technology™ platform, announced today a ... the global biologics business of AstraZeneca. The agreement provides ... Technology and scientific resources for the development of bioprocesses ...
Cached Medicine Technology:Alzheimer's Association Salutes Advocate and Mountaineer Now Climbing Everest as Part of The 7 Summits Climb for Alzheimer's 2Alzheimer's Association Salutes Advocate and Mountaineer Now Climbing Everest as Part of The 7 Summits Climb for Alzheimer's 3Alzheimer's Association Salutes Advocate and Mountaineer Now Climbing Everest as Part of The 7 Summits Climb for Alzheimer's 4Pfenex Announces Strategic Collaboration With MedImmune for the Use of Pfenex Expression Technology™ 2
(Date:12/24/2014)... Dr. Vu Ho, a Dallas based ... practice and med-spa with the addition of new Silk ... cosmetic treatments and services. , “Silk Peel is a ... Dr. Ho. “As a result it can address issues ... spots, discolorations or blemishes.” , Similar to microdermabrasion, ...
(Date:12/24/2014)... The report “Stivarga (Colorectal Cancer) – Forecast and ... landscape, unmet needs, current pipeline and commercial opportunities in ... is used in the treatment of colon or rectal ... prescribed to patients who suffer from advanced gastrointestinal stromal ... multi-kinase inhibitor and it blocks many enzymes which are ...
(Date:12/24/2014)... Dec. 24, 2014 (HealthDay News) -- The holidays can be ... set off by certain foods and drinks. "This is ... can trigger attacks of migraine," Dr. David Dodick, chair of ... the foundation. "It,s important to think through food and ... migraine attack," added Dodick, a professor of neurology at the ...
(Date:12/24/2014)... (HealthDay News) -- Researchers say they have used human ... eggs and sperm. While this had already been ... time that these types of cells -- called primordial ... stem cells, according to the team at the University ... germ cells is one of the earliest events during ...
(Date:12/24/2014)... 24, 2014 Gluten, a protein found ... who have an intolerance to gluten, causing side effects ... migraine headaches, joint pain and fatigue. For this reason, ... that deliver safe and fast weight loss while ... a gluten allergy reaction. These gluten free diet plans ...
Breaking Medicine News(10 mins):Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Expert Offers Tips for Preventing Holiday Migraines 2Health News:Diet Doc Adds Gluten Free Diet Plans to Their Stable of Specialized Weight Loss Programs 2Health News:Diet Doc Adds Gluten Free Diet Plans to Their Stable of Specialized Weight Loss Programs 3
... for the Cure Greater Atlanta Affiliate the First in a Nationwide ... , ATLANTA, May 4 In an effort to increase awareness ... Interactive and BrainJocks have joined ... an avid group of social media users who believe that "friends, ...
... N.C., May 4 Dr. Mehmet Oz on Oprah ... exercise" for people seeking to avoid drugs, surgery, and ... as Qigong, may eventually replace health insurance for many ... growing in popularity in the USA as a low-cost, ...
... May 4 Children hospitalized with concussions should ... in a follow-up exam before returning to regular ... The Children,s Hospital of Philadelphia. Rather than only ... signs after the initial treatment, the Children,s Hospital ...
... insurer reports ... call volume CLEVELAND, May 4 Medical Mutual ... intensifying swine flu outbreak in the United States.In response, the company has posted a message on its ... and member groups to the Centers for Disease Control ...
... Unrestricted Financial Lifeline for Americans Struggling With Serious ... Insurance Company of America (Guardian) supports National Stroke ... owners, benefits decision makers and employees to consider ... have on a person,s financial security.According to the ...
... American Academy of Dermatology introduces new "E" tool for detecting ... to brunch or backyard barbeques is a great way to ... American Academy of Dermatology (Academy) hopes more families will start ... skin cancer . To help detect the warning ...
Cached Medicine News:Health News:Response Mine Interactive and BrainJocks Launch 'Tweets for a Cause' to Support Local Non-Profits 2Health News:Medical Tai Chi (Qigong) - Chinese 'Miracle Exercise' Popular as U.S. Health Costs Rise 2Health News:Medical Tai Chi (Qigong) - Chinese 'Miracle Exercise' Popular as U.S. Health Costs Rise 3Health News:Children with Concussions Require Follow-up Care Before Returning to Play, Say Researchers 2Health News:Children with Concussions Require Follow-up Care Before Returning to Play, Say Researchers 3Health News:Medical Mutual of Ohio Offers Swine Flu Assistance to Customers 2Health News:Guardian Highlights Significance of Critical Illness Insurance During National Stroke Awareness Month 2Health News:Guardian Highlights Significance of Critical Illness Insurance During National Stroke Awareness Month 3Health News:Guardian Highlights Significance of Critical Illness Insurance During National Stroke Awareness Month 4Health News:Dermatologists Encourage People to Screen the One You Love for Skin Cancer 2Health News:Dermatologists Encourage People to Screen the One You Love for Skin Cancer 3Health News:Dermatologists Encourage People to Screen the One You Love for Skin Cancer 4Health News:Dermatologists Encourage People to Screen the One You Love for Skin Cancer 5
Lyphochek Urine Bone Markers Control is a bilevel human urine based control designed to monitor tests for urinary markers of osteoporosis management and bone resorption....
Lyphochek Maternal Serum Control is a trilevel product with analytes at clinically significant levels to monitor maternal serum analysis....
... Immunoassay Plus Control is a ... in today's busy immunoassay laboratory. ... this human serum based control ... separate control products for immunoassay ...
... NsD Nucleic Sample Detection Platform provides fully ... The new platform for molecular pathology ... (CE), with software features that deliver a ... Vidiera NsD has the capacity to run ...
Medicine Products: